U.S. Transplantation Market Size & Outlook, 2023-2030
Related Markets
U.S. transplantation market highlights
- The U.S. transplantation market generated a revenue of USD 5,454.4 million in 2023 and is expected to reach USD 9,632.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, tissue products was the largest revenue generating product in 2023.
- Immunosuppressive Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Transplantation market data book summary
| Market revenue in 2023 | USD 5,454.4 million |
| Market revenue in 2030 | USD 9,632.5 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Tissue products |
| Fastest growing segment | Immunosuppressive Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
| Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.9% of the global transplantation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. transplantation market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,632.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transplantation Market Scope
Transplantation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | https://www.arthrex.com/ |
| BioLife Solutions Inc | View profile | 414 | 3303 Monte Villa Parkway, Suite 310, Bothell, WA, United States, 98021 | https://www.biolifesolutions.com |
| Asahi Kasei Corp | View profile | 48897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | http://www.asahi-kasei.co.jp |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
U.S. transplantation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 58.01% in 2023. Horizon Databook has segmented the U.S. transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the U.S. dominated the market owing to large patient pool, favorable reimbursement policies, and increase in the number of organ transplantation procedures. A large number of people on the waiting list coupled with technological advancements in the field of artificial organs is driving the market. The number of organ donors in the U.S. has increased significantly since the past decade.
Growing demand for kidney transplantation is one of the major drivers of the market. Kidney transplantation witnessed an exponential growth from 16,186 transplants in 2011 to 23,401 transplants in 2019. Increase in aging population is also boosting the need for organ transplantation.
The number of organ transplants in the population older than 65 years is almost double when compared with 2011. However, the highest number of organ transplants are reported to be performed in the age group of 50-64.
Advancements in the field of 3D bioprinting has proven to be crucial in organ transplanting as it is used for developing artificial organs. With increasing cases of organ rejection, demand 3D bioprinting is high. Currently, there are more than 120,000 people in the U.S. who are awaiting organ donation. Thus, demand for 3D printing and organ transplant is expected to rise in the coming years.
Reasons to subscribe to U.S. transplantation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. transplantation market databook
-
Our clientele includes a mix of transplantation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. transplantation market , including forecasts for subscribers. This country databook contains high-level insights into U.S. transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. transplantation market size, by application, 2018-2030 (US$M)
U.S. Transplantation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
